Title:
TARGET-SPECIFIC NUCLEIC ACID MOLECULE HAVING QUINOLINE MODIFICATION
Document Type and Number:
WIPO Patent Application WO/2023/246935
Kind Code:
A1
Abstract:
The present invention relates to the field of biomedicines. Specifically, the present invention relates to a target-specific nucleic acid molecule having a quinoline modification, the quinoline modification being capable of improving the binding affinity between the nucleic acid molecule and a target.
Inventors:
ZHANG GE (CN)
HE YIXIN (CN)
AMU GUBU (CN)
HE YIXIN (CN)
AMU GUBU (CN)
Application Number:
PCT/CN2023/102119
Publication Date:
December 28, 2023
Filing Date:
June 25, 2023
Export Citation:
Assignee:
APTACURE THERAPEUTICS LTD (CN)
International Classes:
C12N15/115; A61K31/7115; A61K48/00; C12N15/11; C12Q1/6811
Foreign References:
| CN103492569A | 2014-01-01 | |||
| CN104975020A | 2015-10-14 | |||
| CN110997917A | 2020-04-10 | |||
| CN104053777A | 2014-09-17 | |||
| CN113025617A | 2021-06-25 | |||
| CN103154014A | 2013-06-12 | |||
| CN107353317A | 2017-11-17 |
Attorney, Agent or Firm:
NTD PATENT & TRADEMARK AGENCY LTD. (CN)
Download PDF:
Previous Patent: COMMUNICATION METHOD AND APPARATUS, RELATED DEVICE, AND STORAGE MEDIUM
Next Patent: IMAGE PROCESSING METHOD AND APPARATUS, AND DEVICE
Next Patent: IMAGE PROCESSING METHOD AND APPARATUS, AND DEVICE